Vision-Sciences' EndoSheath Technology offers patented solution to 'nightmare bacteria'

By Healthcare Facilities Today


ORANGEBURG, N.Y. - An outbreak of "Nightmare Bacteria," also known as the "Super Bug," has raised new alarm bells in the healthcare industry over patient safety. The concern stems from 44 newly reported cases of cross-contamination infections as a result of endoscopic procedures done at Advocate Lutheran General Hospital, located just outside of Chicago.

"This type of outbreak not only undermines patient confidence, it creates stiff potential financial liabilities for hospitals and other healthcare facilities under the Affordable Care Act," said Howard Zauberman, President and Chief Executive Officer of Vision-Sciences, Inc. (Nasdaq:VSCI) -- a company specializing in endoscopes that help safeguard patients from cross-contamination infections caused by conventional endoscopes.

Vision-Sciences (www.visionsciences.com) provides patented technology solutions that safeguard patients with a sterile cover, or EndoSheath(R) Technology, for its endoscopes. This prevents direct contact of the scope with the patient and reduces the risk of contracting infections from bacteria such as the Nightmare Bacteria as a result of endoscopic cross-contamination. In 20 years and with over 5 million procedures performed with EndoSheath(R) Technology, Vision-Sciences has never received a report of cross-contamination.

"We feel confident that our EndoSheath(R) Technology is a win-win for  the healthcare facility and its patients. It is in our best interest to ensure that all healthcare professionals are aware of this alternative to conventional endoscopes while offering a cost cutting and liability reducing solution," said Lewis C. Pell, Chairman and Co-founder of Vision-Sciences.

About Vision-Sciences, Inc.

Vision-Sciences, Inc. designs, develops, manufactures and markets products for flexible endoscopy. The Company's unique product lines feature a streamlined visualization system and proprietary sterile disposable microbial barrier, known as EndoSheath(R) technology, providing users with efficient and cost effective endoscope turnover while enhancing patient safety. Information about Vision-Sciences' products is available at www.visionsciences.com.

Vision-Sciences owns the trademarks Vision Sciences(TM) and Slide-On(TM) and the registered trademarks EndoSheath(R), EndoWipe(R) and The Vision System(R).



January 15, 2014


Topic Area: Press Release


Recent Posts

Avoiding Mistakes in Healthcare Site Selection

Actionable strategies for healthcare systems and medical groups navigating today’s constrained real estate market.


Can Rural Hospitals Be Saved?

More than 700 rural hospitals nationwide face the risk of closure. A new report highlights solutions that could improve long-term sustainability.


Ascension Saint Thomas Breaks Ground on Hospital and Health Campus in Tennessee

The new hospital will open with 44 inpatient beds and will be designed to expand to 132 beds as community needs grow.


The Hidden Risks of QAC Disinfectants in Healthcare Facilities

Quaternary ammonium compounds are a popular disinfectant choice, but they may be causing more harm than good. A review outlines the problems with QACs and offers a solution.


Sprinkler Compliance: Navigating Code Mandates, Renovation Triggers and Patient Safety

As CMS deadlines approach and renovation projects accelerate, healthcare facility managers must understand how NFPA 101, state fire codes and sprinkler design strategies intersect.


 
 


FREE Newsletter Signup Form

News & Updates | Webcast Alerts
Building Technologies | & More!

 
 
 


All fields are required. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.